By API User
12 February 2026 – Sydney, Australia | BlinkLab Limited (ASX:BB1), a leader in AI-powered digital diagnostics, has expanded its U.S. clinical footprint with the onboarding of Drexel University as the ninth site in its pivotal FDA 510(k) trial for BlinkLab Dx 1, the Company’s Software as a Medical Device (SaMD) autism diagnostic aid. The addition of … Continued
By API User
Key points High-profile global AI executive appointment signals next growth phase for Australian healthtech Brad Ryan appointed Chief AI Officer – Former AWS APJ Data & AI Partner Lead and Accenture Managing Director with 30+ years technology leadership experience Platform scale now approaching 1 million diagnostic tests across four countries Singapore expansion positions i-screen as … Continued
By API User
Private Healthcare Australia has welcomed the Federal Government’s legislation to upgrade the Medical Costs Finder website, saying it is a critical step toward tackling Australia’s growing specialist fee crisis. The reform will expand the information available about specialist doctors’ fees, allowing patients to compare typical costs before booking an appointment and better estimate their … Continued
By API User
A new Australian Clinical Practice Guideline for the Appropriate Use of Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) for Post-Traumatic Stress Disorder (PTSD) has been approved by the National Health and Medical Research Council (NHMRC). The Guideline is the world’s first related to MDMA-AP to be developed using the gold standard Grading of Recommendations Assessment, Development and Evaluation … Continued
By API User
Key Facts: ANSTO employs around 190 women in science related roles. ANSTO is actively working to address some of the most challenging issues facing Australia today in human health, the environment, advanced materials and critical minerals. ANSTO Celebrates its Incredible Women in Science ANSTO is privileged to be home to an incredible array of … Continued
By API User
Restylane® Refyne™ and Restylane Defyne™ are the first Optimal Balance Technology (OBT™) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement to the market1,2 This expands Galderma’s Restylane portfolio in Japan to four products, enabling treatment of a wider spectrum of patient and practitioner needs3,4 These two new launches … Continued
By API User
The Royal Australian College of GPs (RACGP) has welcomed changes introduced by the ACT Government that simplify prescribing requirements for ADHD medicines and strengthen support for patients receiving ongoing care. Under the new arrangements, GPs who have completed approved training can now continue prescribing ADHD medication for eligible patients without requiring repeated reviews from a … Continued
By API User
INTERVIEWS AVAILABLE AT EVENT, AND LEADING UP TO This Sunday, February 15, over 8,000 participants, all affected by breast cancer directly or their loves ones, will lace up at Elsternwick Park in Brighton for the annual Carman’s Fun Run. Vision opportunities at one of Melbourne’s most colourful, vibrant fun runs will see a wave of … Continued
By API User
The Royal Australian College of GPs (RACGP) has welcomed plans by the South Australian Government to expand medical training capacity in Mount Gambier through the development of a new education and training facility in partnership with Flinders University. The proposed $13 million centre, to be located adjacent to Mount Gambier Hospital, would significantly enhance existing … Continued
By API User
Nanoplastic exposure can impair the cognitive abilities of fish and could lead to significant impacts on marine species’ ability to survive, according to a new international study. The study by Shantou University and the Chinese Academy of Fisheries Sciences in Guangdong, China, and Charles Darwin University’s (CDU) Research Institute for Northern Argiculture (RINA), explored impact of nanoplastics … Continued
